M. Mayrand

The future of HPV testing in clinical laboratories and applied virology research.

D. Provencher, E. Franco, F. Coutlée, 1997, Clinical and diagnostic virology.

Ensuring a successful transition from Pap to HPV-based primary screening in Canada: a study protocol to investigate the psychosocial correlates of women's screening intentions

J. Waller, G. Zimet, E. McBride, 2022, medRxiv.

The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV

A. Burchell, H. Trottier, D. Rouleau, 2017, The Journal of infectious diseases.

HPV sampling options for cervical cancer screening: preferences of urban-dwelling Canadians in a changing paradigm.

L. Gauvin, G. Datta, M. Mayrand, 2019, Current oncology.

Acceptability of anal cancer screening tests for women living with HIV in the EVVA study.

A. Burchell, F. Coutlée, V. Marcus, 2020, Current oncology.

289 A QUALITATIVE STUDY OF WOMEN’S VIEWS AND EXPERIENCES OF MULTIMODAL PELVIC FLOOR PHYSIOTHERAPY FOR TREATING DYSPAREUNIA AFTER GYNECOLOGICAL CANCER: AN INSIGHT INTO THIS TREATMENT’S ACCEPTABILITY

C. Dumoulin, M. Cyr, M. Morin, 2022, Continence.

Multimodality breast cancer screening in women with a familial or genetic predisposition.

I. Trop, L. Lalonde, D. Provencher, 2010, Current oncology.